227 related articles for article (PubMed ID: 17350953)
21. Biological constraints limit the use of rapamycin-inducible FKBP12-Inp54p for depleting PIP2 in dorsal root ganglia neurons.
Coutinho-Budd JC; Snider SB; Fitzpatrick BJ; Rittiner JE; Zylka MJ
J Negat Results Biomed; 2013 Sep; 12():13. PubMed ID: 24010830
[TBL] [Abstract][Full Text] [Related]
22. Anchor Away: A System for Fast Inhibition of Proteins in Drosophila.
Sanchez Bosch P
Methods Mol Biol; 2022; 2540():239-249. PubMed ID: 35980581
[TBL] [Abstract][Full Text] [Related]
23. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen.
Liberles SD; Diver ST; Austin DJ; Schreiber SL
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):7825-30. PubMed ID: 9223271
[TBL] [Abstract][Full Text] [Related]
24. Expression of budding yeast FKBP12 confers rapamycin susceptibility to the unicellular red alga Cyanidioschyzon merolae.
Imamura S; Ishiwata A; Watanabe S; Yoshikawa H; Tanaka K
Biochem Biophys Res Commun; 2013 Sep; 439(2):264-9. PubMed ID: 23973485
[TBL] [Abstract][Full Text] [Related]
25. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
[TBL] [Abstract][Full Text] [Related]
26. Halcyon days of TOR: Reflections on the multiple independent discovery of the yeast and mammalian TOR proteins.
Livi GP
Gene; 2019 Apr; 692():145-155. PubMed ID: 30639424
[TBL] [Abstract][Full Text] [Related]
27. Tissue-restricted inhibition of mTOR using chemical genetics.
Wassarman DR; Bankapalli K; Pallanck LJ; Shokat KM
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2204083119. PubMed ID: 36095197
[TBL] [Abstract][Full Text] [Related]
28. A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
Shor B; Zhang WG; Toral-Barza L; Lucas J; Abraham RT; Gibbons JJ; Yu K
Cancer Res; 2008 Apr; 68(8):2934-43. PubMed ID: 18413763
[TBL] [Abstract][Full Text] [Related]
29. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
Choi J; Chen J; Schreiber SL; Clardy J
Science; 1996 Jul; 273(5272):239-42. PubMed ID: 8662507
[TBL] [Abstract][Full Text] [Related]
30. A signal-on fluorosensor based on quench-release principle for sensitive detection of antibiotic rapamycin.
Jeong HJ; Itayama S; Ueda H
Biosensors (Basel); 2015 Mar; 5(2):131-40. PubMed ID: 25822756
[TBL] [Abstract][Full Text] [Related]
31. FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle.
MacMillan D; Currie S; McCarron JG
Cell Calcium; 2008 Jun; 43(6):539-49. PubMed ID: 17950843
[TBL] [Abstract][Full Text] [Related]
32. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin.
McMahon LP; Choi KM; Lin TA; Abraham RT; Lawrence JC
Mol Cell Biol; 2002 Nov; 22(21):7428-38. PubMed ID: 12370290
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
Alarcon CM; Heitman J; Cardenas ME
Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
[TBL] [Abstract][Full Text] [Related]
34. In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin.
MacMillan D; Currie S; Bradley KN; Muir TC; McCarron JG
J Cell Sci; 2005 Dec; 118(Pt 23):5443-51. PubMed ID: 16278292
[TBL] [Abstract][Full Text] [Related]
35. Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate.
Sapienza PJ; Mauldin RV; Lee AL
J Mol Biol; 2011 Jan; 405(2):378-94. PubMed ID: 21073880
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals.
Luker KE; Smith MC; Luker GD; Gammon ST; Piwnica-Worms H; Piwnica-Worms D
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12288-93. PubMed ID: 15284440
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
Luengo JI; Yamashita DS; Dunnington D; Beck AK; Rozamus LW; Yen HK; Bossard MJ; Levy MA; Hand A; Newman-Tarr T
Chem Biol; 1995 Jul; 2(7):471-81. PubMed ID: 9383449
[TBL] [Abstract][Full Text] [Related]
38. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans.
Arndt C; Cruz MC; Cardenas ME; Heitman J
Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():1989-2000. PubMed ID: 10463165
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
Land SC; Tee AR
J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
[TBL] [Abstract][Full Text] [Related]
40. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine.
Weisman R; Choder M
J Biol Chem; 2001 Mar; 276(10):7027-32. PubMed ID: 11096119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
